These findings underscore the dual regulatory nature of GEF–H1/RhoA signaling, which remains susceptible to microenvironmental hijacking yet is constrained by tumor‐suppressive kinases (Table 2). This evidence concerns the gene ARHGEF2 and neoplasm.